BeOne’s next-gen BCL2 inhibitor wins FDA approval, taking aim at Venclextanews2026-05-14T10:31:51+00:00May 14th, 2026|Endpoints News|
The current academic system doesn’t incentivise risk-takingnews2026-05-14T08:42:00+00:00May 14th, 2026|Chemistry World|
